5-Azacytidine;4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;4-amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one;5-AC;5 AZC;5-AZCR;Antibiotic u 18496;Azacitidine;Azacytidine;ladakamycin;u 18496;wr 183027;4-amino-1-beta-d-ribofuranosyl-s-triazin-2(1h)-on;5-triazin-2(1h)-one,4-amino-1-beta-d-ribofuranosyl-3;mylosar;nci-c01569;nsc-102816;5-AZAC;4-AMINO-1-(BETA-D-RIBOFURANOSYL)-1,3,5-TRIAZIN-2(1H)-ONE;4-AMINO-1-[(2S,3S,4R,5S)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,3,5-TRIAZIN-2-ONE;5-Azacytidine (Vidaza®,Mylosar®, azacytidine, NSC 102816, NSC 103-627, Ladakamycin, U 18496,);[14C]-Azacitidine;4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;5-AC-15N4;5-Azacitidine;5'-azacytidine;AzGR;Vidaza;Ladakamycin;4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one